Showing results (1871-1880 of 8,887) with videos related to

Sort By:
Pageof 889
European Urology|December 8, 2014
Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysisSilvia Sommariva, Rosanna Tarricone, Massimo Lazzeri, et al.
European Urology|December 4, 2014
Regional geographic variations in kidney cancer incidence rates in European countriesPeng Li, Ariana Znaor, Ivana Holcatova, et al.
European Urology|August 30, 2014
A randomized comparison of a single-incision midurethral sling and a transobturator midurethral sling in women with stress urinary incontinence: results of 12-mo follow-upRené P Schellart, Katrien Oude Rengerink, Frank Van der Aa, et al.
European Urology|August 17, 2015
Nerve-sparing Surgery Technique, Not the Preservation of the Neurovascular Bundles, Leads to Improved Long-term Continence Rates After Radical ProstatectomyUwe Michl, Pierre Tennstedt, Lena Feldmeier, et al.
European Urology|November 4, 2015
Size-adjusted Quantitative Gleason Score as a Predictor of Biochemical Recurrence after Radical ProstatectomyFang-Ming Deng, Nicholas M Donin, Ruth Pe Benito, et al.
European Urology|September 7, 2014
Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomyAndrew J Davidiuk, Alexander S Parker, Colleen S Thomas, et al.
European Urology|September 8, 2014
Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?E Jason Abel, Brian J Linder, Tyler M Bauman, et al.
European Urology|August 25, 2014
Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate CancerTobias Nordström, Andrew Vickers, Melissa Assel, et al.
European Urology|August 25, 2014
Inflammatory biomarkers and bladder cancer prognosis: a systematic reviewAlexandra Masson-Lecomte, Marta Rava, Francisco X Real, et al.
European Urology|August 27, 2014
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosisGail P Risbridger, Renea A Taylor, David Clouston, et al.
Pageof 889